Chronic kidney disease
(CKD)
By Dr. Mujahid.A.Abbass
WKUFOM
Definition
 CKD is Impaired renal function for >3 months based on abnormal
structure or function, or GFR <60mL/min/1.73m 2 for >3 months with or
without evidence of kidney damage
Symptoms usually only occur once stage 4 is reached (GFR <30)
ESRF is defi ned as GFR <15 mL/min/1.73m 2
or need for renal replacement therapy (RRT—dialysis or transplant).
Major causes of CKD
Glomerular diseases
primary glomerular diseases
Focal and segmental glomerulosclerosis
Membranoproliferative glomerulonephritis
IgA nephropathy
Membranous nephropathy
Alport syndrome (hereditary nephritis)
Secondary glomerular diseases
Diabetic nephropathy
Amyloidosis
Amyloidosis
HIV-associated nephropathy
Collagen-vascular diseases (eg, SLE)
HCV-associated membranoproliferative glomerulonephritis
Tubulointerstitial nephritis
Drug hypersensitivity
Heavy metals
Analgesic nephropathy
Reflux/chronic pyelonephritis
Sickle cell nephropathy
Idiopathic
Cystic diseases
Polycystic kidney disease
Medullary cystic disease
Obstructive nephropathies
Prostatic disease
Nephrolithiasis
Retroperitoneal fibrosis/tumor
Congenital
Vascular diseases
Hypertensive nephrosclerosis
Renal artery stenosis
Reversible causes of kidney injury
Classifications
Stage GFR
(mL/min)
Notes
1 >90 Slight GFR with other evidence of renal damage*
2 60-89 Slight GFR with other evidence of renal damage*
3 A 45-59 Moderate GFR with or without evidence of other renal
3 B 30-44 damage*
4 15-20 Severe GFR with or without evidence of renal damage*
5 <15 Established renal failure
Screening for risky patients with:
i. Diabetes mellitus
ii. Hypertension
iii. Cardiovascular disease (IHD, peripheral vascular disease, cerebrovascular
disease)
iv. Structural renal disease, known stones or BPH
v. Recurrent UTIS or those with childhood history of vesicoureteric refl ux
vi. Multisystem disorders which could involve the kidney, eg SLE
vii. Family history of ESRF or known hereditary disease, eg APKD
viii.Opportunistic detection of haematuria or proteinuria Some guidelines also
suggest routine screening in those
ix. Age >60yrs
Causes of anemia in CKD
Relative defiiency of erythropoietin
Diminished red blood cell survival
Bleeding diathesis
Iron defiiency
Hyperparathyroidism/bone marrow firosis
“Chronic inflmmation”
Folate or vitamin B12 defiiency
Hemoglobinopathy
omorbid conditions: hypo/hyperthyroidism, pregnancy,
HIV-associated disease, autoimmune disease, immunosuppressive drugs
Evaluation
1-History :
•Possible cause: ask about previous UTIS, LUTS (lower urinary tract
symptoms, PMH of HTN, DM, IHD, systemic disorder, renal colic. Check drug
history and family history (draw tree if positive). Systems review: always be on the
lookout for more than is immediately obvious, possible rare causes, symptoms
suggestive of systemic disorder or malignancy.
•Current state: aemic symptoms In women ask about amenorrhoea, in men
impotence. Symptoms become more common with progression through CKD
stages 4 and 5 but if slow onset many patients remain asymptomatic. Check for
oliguria, dyspnoea, ankle swelling.
Symptoms and signs of uremia.
Organ System Symptoms Signs
General Fatigue,weakness Sallow-appearing, chronically ill
Skin Pruritus, easy bruisability Pallor, ecchymoses, excoriations,edema,
xerosis
ENT Metallic taste in mouth, Urinous breath
epistaxis
Eye Pale conjunctiva
Pulmonary Shortness of breath Rales, pleural effusion
Cardiovascular Dyspnea on exertion,retrosternal pain on
Inspiration (pericarditis) Hypertension,
cardiomegaly,
friction rub
Gastrointestinal Anorexia, nausea,
vomiting, hiccups -----------
Genitourinary Nocturia, erectile dysfunction Isosthenuria
Neuromuscular Restless legs, numbness
and cramps in legs
Neurologic Generalized irritability Stupor, asterixis,
and inability to myoclonus,
peripheral
neuropathy
concentrate,
decreased libido
2-Examination :
You are looking for:
1Cause of ESRF/CKD, eg polycystic kidneys, signs of IHD, DM
2Current mode of renal replacement therapy (RRT) and any complications, eg
transplant + skin malignancy from immunosuppression
3Previous types of RRT and any complications, eg arteriovenous fi stula +
parathyroidectomy scar
Periphery:
Hypertension, arteriovenous fi stula (thrill, bruit, has it been recently
needled?), signs of previous transplant—bruising from steroids, skin malignancy
from immunosuppression.
Face: Pallor of anaemia, yellow tinge of uraemia, gum hypertrophy from
ciclosporin, cushingoid appearance from steroids.
Neck : Current or previous tunnelled line insertion (if removed, look for a
small scar
over internal jugular, and a larger scar in ‘breast pocket’ area from the exit site),
scar from parathyroidectomy.
Abdomen: PD catheter or sign of previous catheter (small midline scar just
below umbilicus and small round scar to side of midline from exit site), signs of
previous transplant (hockey-stick scar, palpable mass), ballotable polycystic
kidneys ± liver.
Elsewhere: Signs of diabetic neuropathy, retinopathy, cardiovascular or
peripheral vascular disease
3-Tests :
i. Blood: Hb (normochromic, normocytic anaemia), ESR, U&E, glucose
(DM),low Ca2+, high PO43 –, high alk phos (renal osteodystrophy).high PTH
if CKD stage 3 or more
ii. Urine: Dipstick, MC&S, albumin: creatinine ratio or protein : creatinine
ratio
iii. Imaging: USS to check size, anatomy and corticomedullary dif
erentiation. In CKD kidneys are usually small (<9cm) but can be enlarged in
infi ltrative disorders (amyloid, myeloma), APKD and DM. If asymmetrical
consider MAG3 renogram to look at contribution of each kidney to overall
function
iv. Histology: Consider renal biopsy if rapidly progressive disease or
unclear cause and normal sized kidneys.
Clinical action plan
Stage Descrepion GFR,mL/minPer
1.73 m2
Action
1 Kidney damage with normal or ↑ GFR ≥90 Diagnosis and treatment, treatment
of comorbid conditions,slowing
progression, CVD risk reduction
2 Kidney damage with mild ↓GFR 60–89 Estimating progression
3 Moderate ↓GFR 30–59 Evaluating and treating
complications
4 Severe ↓ GFR 15–29 Preparation for kidney replacement
therapy
5 Kidney failure <15 (or dialysis) Kidney replacement (if uremia
present)
Essential of diagnosis:
▶ Decline in the GFR over months to years
▶ Persistent proteinuria or abnormal renal morphology may be present.
▶ Hypertension in most cases.
▶ Symptoms and signs of uremia when nearing endstage disease.
▶ Bilateral small or echogenic kidneys on ultrasound in advanced disease.
Treatments aim to
• slowing tHe progression of CKd
• reducing intraglomerular Hypertension and proteinuria
• slowing progression of diabetic renal disease
• Control of blood glucose
• Control of blood pressure and proteinuria
• protein restriction
• Managing other Complections of CKD such as:
Medication dose adjustment
preparation for renal replacement therapy(dialysis+transplantation)
patient education
Calciphylaxis.
Complications
A. Cardiovascular Complications
i. Hypertension
ii. Coronary artery diseas
iii. Heart failure
iv. Pericarditis
B. Disorders of Mineral Metabolism
i. renal osteodystrophy,
ii. osteitis fibrosa cystica,
iii. Adynamic bone disease
iv. Osteomalacia
C. Hematologic Complications
i- Anemia
ii- Coagulopathy
D. Hyperkalemia
E. Acid–Base Disorders
F. Neurologic Complications
G. Endocrine Disorders

Chronic renal Disease\failure (CKD)

  • 1.
    Chronic kidney disease (CKD) ByDr. Mujahid.A.Abbass WKUFOM
  • 2.
    Definition  CKD isImpaired renal function for >3 months based on abnormal structure or function, or GFR <60mL/min/1.73m 2 for >3 months with or without evidence of kidney damage Symptoms usually only occur once stage 4 is reached (GFR <30) ESRF is defi ned as GFR <15 mL/min/1.73m 2 or need for renal replacement therapy (RRT—dialysis or transplant).
  • 3.
    Major causes ofCKD Glomerular diseases primary glomerular diseases Focal and segmental glomerulosclerosis Membranoproliferative glomerulonephritis IgA nephropathy Membranous nephropathy Alport syndrome (hereditary nephritis) Secondary glomerular diseases Diabetic nephropathy Amyloidosis Amyloidosis HIV-associated nephropathy Collagen-vascular diseases (eg, SLE) HCV-associated membranoproliferative glomerulonephritis
  • 4.
    Tubulointerstitial nephritis Drug hypersensitivity Heavymetals Analgesic nephropathy Reflux/chronic pyelonephritis Sickle cell nephropathy Idiopathic Cystic diseases Polycystic kidney disease Medullary cystic disease Obstructive nephropathies Prostatic disease Nephrolithiasis Retroperitoneal fibrosis/tumor Congenital Vascular diseases Hypertensive nephrosclerosis Renal artery stenosis
  • 5.
    Reversible causes ofkidney injury
  • 6.
    Classifications Stage GFR (mL/min) Notes 1 >90Slight GFR with other evidence of renal damage* 2 60-89 Slight GFR with other evidence of renal damage* 3 A 45-59 Moderate GFR with or without evidence of other renal 3 B 30-44 damage* 4 15-20 Severe GFR with or without evidence of renal damage* 5 <15 Established renal failure
  • 7.
    Screening for riskypatients with: i. Diabetes mellitus ii. Hypertension iii. Cardiovascular disease (IHD, peripheral vascular disease, cerebrovascular disease) iv. Structural renal disease, known stones or BPH v. Recurrent UTIS or those with childhood history of vesicoureteric refl ux vi. Multisystem disorders which could involve the kidney, eg SLE vii. Family history of ESRF or known hereditary disease, eg APKD viii.Opportunistic detection of haematuria or proteinuria Some guidelines also suggest routine screening in those ix. Age >60yrs
  • 10.
    Causes of anemiain CKD Relative defiiency of erythropoietin Diminished red blood cell survival Bleeding diathesis Iron defiiency Hyperparathyroidism/bone marrow firosis “Chronic inflmmation” Folate or vitamin B12 defiiency Hemoglobinopathy omorbid conditions: hypo/hyperthyroidism, pregnancy, HIV-associated disease, autoimmune disease, immunosuppressive drugs
  • 11.
    Evaluation 1-History : •Possible cause:ask about previous UTIS, LUTS (lower urinary tract symptoms, PMH of HTN, DM, IHD, systemic disorder, renal colic. Check drug history and family history (draw tree if positive). Systems review: always be on the lookout for more than is immediately obvious, possible rare causes, symptoms suggestive of systemic disorder or malignancy. •Current state: aemic symptoms In women ask about amenorrhoea, in men impotence. Symptoms become more common with progression through CKD stages 4 and 5 but if slow onset many patients remain asymptomatic. Check for oliguria, dyspnoea, ankle swelling.
  • 12.
    Symptoms and signsof uremia. Organ System Symptoms Signs General Fatigue,weakness Sallow-appearing, chronically ill Skin Pruritus, easy bruisability Pallor, ecchymoses, excoriations,edema, xerosis ENT Metallic taste in mouth, Urinous breath epistaxis Eye Pale conjunctiva Pulmonary Shortness of breath Rales, pleural effusion Cardiovascular Dyspnea on exertion,retrosternal pain on Inspiration (pericarditis) Hypertension, cardiomegaly, friction rub Gastrointestinal Anorexia, nausea, vomiting, hiccups ----------- Genitourinary Nocturia, erectile dysfunction Isosthenuria
  • 13.
    Neuromuscular Restless legs,numbness and cramps in legs Neurologic Generalized irritability Stupor, asterixis, and inability to myoclonus, peripheral neuropathy concentrate, decreased libido
  • 14.
    2-Examination : You arelooking for: 1Cause of ESRF/CKD, eg polycystic kidneys, signs of IHD, DM 2Current mode of renal replacement therapy (RRT) and any complications, eg transplant + skin malignancy from immunosuppression 3Previous types of RRT and any complications, eg arteriovenous fi stula + parathyroidectomy scar Periphery: Hypertension, arteriovenous fi stula (thrill, bruit, has it been recently needled?), signs of previous transplant—bruising from steroids, skin malignancy from immunosuppression.
  • 15.
    Face: Pallor ofanaemia, yellow tinge of uraemia, gum hypertrophy from ciclosporin, cushingoid appearance from steroids. Neck : Current or previous tunnelled line insertion (if removed, look for a small scar over internal jugular, and a larger scar in ‘breast pocket’ area from the exit site), scar from parathyroidectomy. Abdomen: PD catheter or sign of previous catheter (small midline scar just below umbilicus and small round scar to side of midline from exit site), signs of previous transplant (hockey-stick scar, palpable mass), ballotable polycystic kidneys ± liver. Elsewhere: Signs of diabetic neuropathy, retinopathy, cardiovascular or peripheral vascular disease
  • 16.
    3-Tests : i. Blood:Hb (normochromic, normocytic anaemia), ESR, U&E, glucose (DM),low Ca2+, high PO43 –, high alk phos (renal osteodystrophy).high PTH if CKD stage 3 or more ii. Urine: Dipstick, MC&S, albumin: creatinine ratio or protein : creatinine ratio
  • 17.
    iii. Imaging: USSto check size, anatomy and corticomedullary dif erentiation. In CKD kidneys are usually small (<9cm) but can be enlarged in infi ltrative disorders (amyloid, myeloma), APKD and DM. If asymmetrical consider MAG3 renogram to look at contribution of each kidney to overall function iv. Histology: Consider renal biopsy if rapidly progressive disease or unclear cause and normal sized kidneys.
  • 18.
    Clinical action plan StageDescrepion GFR,mL/minPer 1.73 m2 Action 1 Kidney damage with normal or ↑ GFR ≥90 Diagnosis and treatment, treatment of comorbid conditions,slowing progression, CVD risk reduction 2 Kidney damage with mild ↓GFR 60–89 Estimating progression 3 Moderate ↓GFR 30–59 Evaluating and treating complications 4 Severe ↓ GFR 15–29 Preparation for kidney replacement therapy 5 Kidney failure <15 (or dialysis) Kidney replacement (if uremia present)
  • 19.
    Essential of diagnosis: ▶Decline in the GFR over months to years ▶ Persistent proteinuria or abnormal renal morphology may be present. ▶ Hypertension in most cases. ▶ Symptoms and signs of uremia when nearing endstage disease. ▶ Bilateral small or echogenic kidneys on ultrasound in advanced disease.
  • 20.
    Treatments aim to •slowing tHe progression of CKd • reducing intraglomerular Hypertension and proteinuria • slowing progression of diabetic renal disease • Control of blood glucose • Control of blood pressure and proteinuria • protein restriction • Managing other Complections of CKD such as: Medication dose adjustment preparation for renal replacement therapy(dialysis+transplantation) patient education
  • 21.
  • 22.
    Complications A. Cardiovascular Complications i.Hypertension ii. Coronary artery diseas iii. Heart failure iv. Pericarditis
  • 23.
    B. Disorders ofMineral Metabolism i. renal osteodystrophy, ii. osteitis fibrosa cystica, iii. Adynamic bone disease iv. Osteomalacia
  • 24.
    C. Hematologic Complications i-Anemia ii- Coagulopathy D. Hyperkalemia E. Acid–Base Disorders F. Neurologic Complications G. Endocrine Disorders

Editor's Notes

  • #9 Left: Low-power photomicrograph of a normal kidney showing normal glomeruli and healthy tubulointerstitium without firosis. Right: Low-power photomicrograph of chronic kidney disease with sclerosis of many glomeruli and severe tubulointerstitial firosis
  • #22 This peritoneal dialysis patient was on chronic warfarin therapy for prophylactic anticoagulation for a mechanical heart valve. She slept with the dialysis catheterpressed between her legs. A small abrasion was followedby progressive skin necrosis along the catheter tract on her inner thighs. Despite treatment with hyperbaric oxygen, intravenous thiosulfate, and discontinuation of warfarin, she succumbed to systemic complications of the necrotic process.